Thursday, March 31, 2022

80 percent of Evusheld doses are unused because no one knows about this drug

The New York Times "The Morning" (March 28, 2022)addressed the issue of the immunocompromised, who have ineffective protection with Covid-19 protection. There is a drug called Evusheld, developed by AstraZeneca, but no one seems to know about it. I blogged about it right after I received my two injections. It provides months of protection. 850,000 people could get added protection but about 80 percent of the doses are sitting in hospitals, warehouses, and pharmacies unused.

Why is this happening? It is because no one knows about it. Or no one knows who qualifies.

We need a plan, people!

No comments:

Post a Comment